Found: 21
Select item for more details and to access through your institution.
A phase I pharmacokinetic and pharmacodynamic study of GTI-2040 in combination with gemcitabine in patients with solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correlation of plasma erlotinib trough concentration with skin rash in Chinese NSCLC patients harboring exon 19 deletion mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A lung squamous carcinoma patient with ROS1 rearrangement sensitive to crizotinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A safety, tolerability, and pharmacokinetic analysis of two phase I studies of multitargeted small molecule tyrosine kinase inhibitor XL647 with an intermittent and continuous dosing schedule in patients with advanced solid malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil<sup>®</sup> or Caelyx<sup>®</sup> in advanced ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of <sup>14</sup>C-plitidepsin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brazilin induces FOXO3A-dependent autophagic cell death by disturbing calcium homeostasis in osteosarcoma cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article